Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 5/20 | 0.39 |
| ▸ | BRD2 | P25440 | 3/20 | 0.39 |
| ▸ | BRD3 | Q15059 | 3/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 10/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 9/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 9/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 9/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 9/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 9/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 9/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 9/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14557667 | 0.86 | PPARG (0.42) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL14557712 | 0.85 | KDM4E (0.38) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL14557950 | 0.84 | PPARG (0.41) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL5155947 | 0.84 | CNR2 (0.40) | BRD4BRD2BRD3HDAC3HDAC1 | |
| SCHEMBL5155937 | 0.84 | CNR2 (0.40) | BRD4BRD2BRD3HDAC3HDAC1 | |
| SCHEMBL14557669 | 0.84 | PPARG (0.43) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL5155943 | 0.84 | BRD4 (0.39) | BRD4BRD2BRD3HDAC3HDAC1 | |
| SCHEMBL14557677 | 0.83 | MAPK1 (0.41) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL14557678 | 0.83 | PPARG (0.39) | HDAC3HDAC1HDAC4HDAC7HDAC2 | |
| SCHEMBL14557718 | 0.83 | KDM4E (0.40) | HDAC3HDAC1HDAC4HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1912970-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-23 | — | — | EP | claimed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | claimed |
| WO-2007017289-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | WO | claimed |
| EP-1912970-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-23 | — | — | EP | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| US-20070060573-A1 | Acyltryptophanols | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-03-15 | — | — | US | disclosed |
| WO-2007017289-A2 | ACYLTRYPTOPHANOLS FOR FERTILITY CONTROL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060573-A1 | Acyltryptophanols | FSHR, NPY1R, NPY2R | BRD4 3122/4885BRD2 3396/4885BRD3 2859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.